Editorial Comment on: Neoadjuvant Chemotherapy in Advanced Penile Carcinoma

European Urology

Volumn 52, Issue 2, 2007, Pages 494-

  Pizzocaro, Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVOR; DRUG TOLERABILITY; HEAD AND NECK CARCINOMA; HUMAN; NOTE; PENIS CARCINOMA; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FLUOROURACIL; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PENILE NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE;

EID: 34250759369     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.02.007     Document Type: Note

References (4)

1. Solsona E., Algaba F., Horenblas S., Pizzocaro G., and Windahl T. EAU guidelines on penile cancer. Eur Urol 46 (2004) 1-8
2. Pizzocaro G., Tan W.W., and Dreicer R. Chemotherapy for penile cancer. In: Vogelzang N.J., Scardino P.T., Shipley W.U., Debruyne F.M.J., and Linehen W.M. (Eds). Comprehensive textbook of genitourinary oncology. 3rd ed. (2006), Lippincott Williams & Wilkins, Philadelphia 827-831
3. Leijte J.A.P., Kerst J.M., Bais E., et al. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol. 52 (2007) 488-494
4. Hitt R., Lopez-Pousa A., Martinez-Trufero J., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 (2005) 8636-8645